COMPLEMENT-MEDIATED INHIBITION OF IMMUNE PRECIPITATION .1. ROLE OF THE CLASSICAL AND ALTERNATIVE PATHWAYS
- 1 January 1982
- journal article
- research article
- Vol. 47 (3) , 555-562
Abstract
The mechanisms involved in [human] complement(C)-mediated inhibition of immune precipitation was studied using radiolabeled BSA [bovine serum albumin] and rabbit anti-BSA. Purified proenzyme C1 was capable of maintaining the complexes in soluble form during the 1st few minutes of reaction; immune precipitation was immediate in the presence of purified C1q of C1 + EDTA. In C1q deficient serum, initial immune aggregation was followed by partial solubilization of the formed precipitate similar to that obtained with normal human serum in the presence of Mg EGTA. In C2-deficient serum precipitation occurred at a slow rate. Repletion of the deficient component (C1q or C2, respectively) restored fully inhibition of precipitation. These experiments establish a critical role for the classical pathway in this phenomenon. By contrast, the role of the alternative pathway in maintaining complexes in solution was less important; only partial and delayed precipitation occurred in sera depleted of factor D or factor B. Factor B and factor D restored normal C activity to depleted sera. No precipitation was detected in a reagent depleted of properdin. The mechanisms of inhibition of precipitation are therefore distinct from those responsible for solubilization of an immune precipitate, which is largely dependent on the alternative pathway.This publication has 20 references indexed in Scilit:
- VALUE OF IMMUNE-COMPLEX ASSAYS IN DIAGNOSIS AND MANAGEMENTThe Lancet, 1978
- Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.Journal of Clinical Investigation, 1978
- Evidences proving the intercalation hypothesis of the C-mediated complex release activity (CRA)Immunochemistry, 1978
- Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.The Journal of Experimental Medicine, 1977
- The unactivated form of the first component of human complement, C1Biochemical Journal, 1976
- Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.Journal of Clinical Investigation, 1976
- Studies on the mechanism of solubilization of immune precipitates by serum.The Journal of Experimental Medicine, 1976
- A new complement function: solubilization of antigen-antibody aggregates.Proceedings of the National Academy of Sciences, 1975
- The purification of specific antibody as F(ab′)2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigensImmunochemistry, 1971
- Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion.1970